{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:16:34Z","timestamp":1761920194276,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Clinique et Biologique"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.tracli.2016.08.003","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T13:12:51Z","timestamp":1473426771000},"page":"229-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Major obstetric hemorrhage"],"prefix":"10.1016","volume":"23","author":[{"given":"A.","family":"Le Gouez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.J.","family":"Mercier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tracli.2016.08.003_bib0140","series-title":"Obstetric anesthesia, principles and practice","first-page":"662","article-title":"Antepartum and postpartum hemorrhage","author":"Mayer","year":"2004"},{"key":"10.1016\/j.tracli.2016.08.003_bib0145","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/bja\/aer192","article-title":"Saving mothers\u2019 lives: reviewing maternal deaths to make motherhood safer: 2006\u20138: a review","volume":"107","author":"McClure","year":"2011","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.tracli.2016.08.003_bib0150","first-page":"69","article-title":"Factors associated with postpartum hemorrhage with vaginal birth","volume":"77","author":"Combs","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.tracli.2016.08.003_bib0155","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejogrb.2015.12.012","article-title":"Postpartum hemorrhage: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF): in collaboration with the French Society of Anesthesiology and Intensive Care (SFAR)","volume":"198","author":"Sentilhes","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.tracli.2016.08.003_bib0160","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejogrb.2003.04.001","article-title":"Criteria for transfusion in severe postpartum hemorrhage: analysis of practice and risk factors","volume":"112","author":"Reyal","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.tracli.2016.08.003_bib0165","first-page":"209","article-title":"[Practical use of sulprostone in the treatment of hemorrhages during delivery]","volume":"24","author":"Goffinet","year":"1995","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.tracli.2016.08.003_bib0170","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/01.ogx.0000271137.81361.93","article-title":"Systematic review of conservative management of postpartum hemorrhage: what to do when medical treatment fails","volume":"62","author":"Doumouchtsis","year":"2007","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.tracli.2016.08.003_bib0175","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1097\/AOG.0000000000000021","article-title":"Massive blood transfusion during hospitalization for delivery in New York State, 1998\u20132007","volume":"122","author":"Mhyre","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.tracli.2016.08.003_bib0180","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/ACO.0b013e32833835a2","article-title":"Use of clotting factors and other prohemostatic drugs for obstetric hemorrhage","volume":"23","author":"Mercier","year":"2010","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1016\/j.tracli.2016.08.003_bib0185","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1213\/ANE.0000000000000450","article-title":"Medical advances in the treatment of postpartum hemorrhage","volume":"119","author":"Ducloy-Bouthors","year":"2014","journal-title":"Anesth Analg"},{"key":"10.1016\/j.tracli.2016.08.003_bib0190","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1537-2995.2007.01160.x","article-title":"Proactive administration of platelets and plasma for patients with a ruptured abdominal aortic aneurysm: evaluating a change in transfusion practice","volume":"47","author":"Johansson","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.tracli.2016.08.003_bib0195","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/01.ta.0000250497.08101.8b","article-title":"Fresh frozen plasma should be given earlier to patients requiring massive transfusion","volume":"62","author":"Gonzalez","year":"2007","journal-title":"J Trauma"},{"key":"10.1016\/j.tracli.2016.08.003_bib0200","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1538-7836.2007.02297.x","article-title":"The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage","volume":"5","author":"Charbit","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tracli.2016.08.003_bib0205","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijoa.2013.01.002","article-title":"Postpartum hemorrhage and low fibrinogen levels: the past, present and future","volume":"22","author":"Butwick","year":"2013","journal-title":"Int J Obstet Anesth"},{"key":"10.1016\/j.tracli.2016.08.003_bib0210","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1186\/cc10143","article-title":"High-dose tranexamic acid reduces blood loss in postpartum hemorrhage","volume":"15","author":"Ducloy-Bouthors","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.tracli.2016.08.003_bib0215","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2393-9-29","article-title":"Anti-fibrinolytic agents in postpartum hemorrhage: a systematic review","volume":"9","author":"Ferrer","year":"2009","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.tracli.2016.08.003_bib0220","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant hemorrhage (CRASH-2): a randomised, placebo-controlled trial","volume":"376","author":"Shakur","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.tracli.2016.08.003_bib0225","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ijoa.2007.01.014","article-title":"Blood conservation techniques in obstetrics: a UK perspective","volume":"16","author":"Catling","year":"2007","journal-title":"Int J Obstet Anesth"},{"key":"10.1016\/j.tracli.2016.08.003_bib0230","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijoa.2004.09.002","article-title":"Facilities for blood salvage (cell saver technique) must be available in every obstetric theatre","volume":"14","author":"Clark","year":"2005","journal-title":"Int J Obstet Anesth"},{"key":"10.1016\/j.tracli.2016.08.003_bib0235","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1471-0528.2006.01156.x","article-title":"The use of recombinant activated factor VII in obstetric and gynaecological hemorrhage","volume":"114","author":"Franchini","year":"2007","journal-title":"BJOG"},{"key":"10.1016\/j.tracli.2016.08.003_bib0240","first-page":"1174","article-title":"Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII","volume":"101","author":"Bouwmeester","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.tracli.2016.08.003_bib0245","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.annfar.2004.09.005","article-title":"[Recombinant activated factor VII as a life-saving therapy for severe postpartum hemorrhage unresponsive to conservative traditional management]","volume":"23","author":"Brice","year":"2004","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1016\/j.tracli.2016.08.003_bib0250","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1471-0528.2004.00058.x","article-title":"Prolonged treatment of massive postpartum hemorrhage with recombinant factor VIIa: case report and review of the literature","volume":"111","author":"Boehlen","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.tracli.2016.08.003_bib0255","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/bja\/aei094","article-title":"Recombinant factor VIIa for life-threatening postpartum hemorrhage","volume":"94","author":"Ahonen","year":"2005","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.tracli.2016.08.003_bib0260","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1097\/01.AOG.0000288515.48066.99","article-title":"Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000\u20132004","volume":"110","author":"Alfirevic","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.tracli.2016.08.003_bib0265","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/jth.12844","article-title":"Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial","volume":"13","author":"Lavigne-Lissalde","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tracli.2016.08.003_bib0270","doi-asserted-by":"crossref","first-page":"R120","DOI":"10.1186\/cc5026","article-title":"Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding\u00a0\u2013\u00a0a European perspective","volume":"10","author":"Vincent","year":"2006","journal-title":"Crit Care"}],"container-title":["Transfusion Clinique et Biologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782016300386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1246782016300386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:36:38Z","timestamp":1761129398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1246782016300386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S1246782016300386"],"URL":"https:\/\/doi.org\/10.1016\/j.tracli.2016.08.003","relation":{},"ISSN":["1246-7820"],"issn-type":[{"type":"print","value":"1246-7820"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Major obstetric hemorrhage","name":"articletitle","label":"Article Title"},{"value":"Transfusion Clinique et Biologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tracli.2016.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}